tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

VNDA Stock Latest News

Vanda Sets 2025 Executive Compensation Plans
Company AnnouncementsVanda Sets 2025 Executive Compensation Plans
46s ago
8K
VNDA
Vanda Pharmaceuticals: Promising Revenue Growth and Strategic Pipeline Drive Buy Rating
PremiumRatings
Vanda Pharmaceuticals: Promising Revenue Growth and Strategic Pipeline Drive Buy Rating
2d ago
VNDA
Vanda Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
PremiumThe Fly
Vanda Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
2d ago
VNDA
Vanda Pharmaceuticals’ Earnings Call: Mixed Results and Future Optimism
PremiumCompany Announcements
Vanda Pharmaceuticals’ Earnings Call: Mixed Results and Future Optimism
6d ago
VNDA
Vanda Pharmaceuticals Sees Revenue Growth Amid Strategic Expansions
PremiumCompany Announcements
Vanda Pharmaceuticals Sees Revenue Growth Amid Strategic Expansions
7d ago
VNDA
Vanda Pharmaceuticals sees FY25 revenue $210M-$250M, consensus $284.9M
PremiumThe FlyVanda Pharmaceuticals sees FY25 revenue $210M-$250M, consensus $284.9M
7d ago
VNDA
Vanda Pharmaceuticals targets total annual revenue in excess of $1B in 2030
Premium
The Fly
Vanda Pharmaceuticals targets total annual revenue in excess of $1B in 2030
7d ago
VNDA
Vanda Pharmaceuticals reports Q EPS (8c) vs. (4c) last year
Premium
The Fly
Vanda Pharmaceuticals reports Q EPS (8c) vs. (4c) last year
7d ago
VNDA
Vanda’s Strategic In-Licensing of Imsidolimab Signals Promising Growth in GPP Market
PremiumRatings
Vanda’s Strategic In-Licensing of Imsidolimab Signals Promising Growth in GPP Market
16d ago
VNDA
AnaptysBio, Vanda announce exclusive global license agreement for Vanda
PremiumThe Fly
AnaptysBio, Vanda announce exclusive global license agreement for Vanda
17d ago
ANAB
VNDA
Vanda Pharmaceuticals and AnaptysBio to develop and market imsidolimab
PremiumThe Fly
Vanda Pharmaceuticals and AnaptysBio to develop and market imsidolimab
17d ago
ANAB
VNDA
Vanda Pharmaceuticals (VNDA) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Vanda Pharmaceuticals (VNDA) Q4 Earnings Cheat Sheet
18d ago
VNDA
Vanda Pharmaceuticals Files New Drug Application
PremiumCompany AnnouncementsVanda Pharmaceuticals Files New Drug Application
24d ago
8K
VNDA
Vanda Pharmaceuticals accepts FDA opportunity for a hearing in tradipitant NDA
Premium
The Fly
Vanda Pharmaceuticals accepts FDA opportunity for a hearing in tradipitant NDA
24d ago
VNDA
Vanda Pharmaceuticals issues letter to FDA on faulty gastroparesis NDA review
Premium
The Fly
Vanda Pharmaceuticals issues letter to FDA on faulty gastroparesis NDA review
1M ago
VNDA
Vanda Pharmaceuticals: Orphan Drug Designation Granted for VGT-1849A
PremiumThe Fly
Vanda Pharmaceuticals: Orphan Drug Designation Granted for VGT-1849A
2M ago
VNDA
Vanda Pharmaceuticals treatment of polycythemia vera granted orphan status
PremiumThe Fly
Vanda Pharmaceuticals treatment of polycythemia vera granted orphan status
2M ago
VNDA
Vanda Pharmaceuticals Reports Strong Q3 2024 Growth
PremiumCompany Announcements
Vanda Pharmaceuticals Reports Strong Q3 2024 Growth
4M ago
VNDA
Vanda Pharmaceuticals narrows 2024 revenue view to $190M-$210M from $180M-$210M
PremiumThe Fly
Vanda Pharmaceuticals narrows 2024 revenue view to $190M-$210M from $180M-$210M
4M ago
VNDA
Vanda Pharmaceuticals reports Q3 EPS (9c), consensus (16c)
PremiumThe FlyVanda Pharmaceuticals reports Q3 EPS (9c), consensus (16c)
4M ago
VNDA
Wingstop upgraded, Estee Lauder downgraded: Wall Street’s top analyst calls
Premium
The Fly
Wingstop upgraded, Estee Lauder downgraded: Wall Street’s top analyst calls
4M ago
EL
RF
Vanda Pharmaceuticals initiated with a Buy at H.C. Wainwright
Premium
The Fly
Vanda Pharmaceuticals initiated with a Buy at H.C. Wainwright
4M ago
VNDA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >